jueves, 1 de agosto de 2019

Explained: What’s at stake in India’s biggest ever trial of tuberculosis vaccines | Explained News, The Indian Express

Explained: What’s at stake in India’s biggest ever trial of tuberculosis vaccines | Explained News, The Indian Express
Written by Anuradha Mascarenhas |Pune |Updated: August 1, 2019 6:56:59 am

Explained: What’s at stake in India’s biggest ever trial of tuberculosis vaccines

Treating TB requires a multi-drug course of treatment lasting six months; longer still for treating drug-resistant TB. Treatment failure and recurrence can have devastating consequences.


icmr new tuberculosis vaccines, Indian Council of Medical Research, ICMR new tb vaccines, tb vaccines,
India contributes to 27 per cent of the global TB burden; the highest share globally. (Source: File Photo)

On July 15, the Indian Council of Medical Research (ICMR) launched India’s first large-scale trial for two new tuberculosis (TB) vaccines.

No hay comentarios: